EXPANDING THE EVIDENCE
Three more dermatologists are joining Dr. Ross and Dr. Munavalli as investigators in the second study investigating NPS for the treatment of non-genital warts. They aim to enroll 60 subjects across their ve sites. Patients will be able to receive a total of four NPS treatments with a 30-day interval between treatments.
As of October 2019, 33 patients were enrolled, and the majority of their warts had been refractory to prior treatments.
The treatments are being performed with one of five tip sizes, depending on wart size. A range of treatment settings are being evaluated with the aim of finding parameters that provide the best benefit:risk ratio.
Drs. Munavalli and Ross are investigators and members of the scientific advisory board for Pulse Biosciences.